These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 22935909)

  • 1. Development of artemisinin compounds for cancer treatment.
    Lai HC; Singh NP; Sasaki T
    Invest New Drugs; 2013 Feb; 31(1):230-46. PubMed ID: 22935909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.
    Lai H; Sasaki T; Singh NP
    Expert Opin Ther Targets; 2005 Oct; 9(5):995-1007. PubMed ID: 16185154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
    Nakase I; Lai H; Singh NP; Sasaki T
    Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment.
    Li D; Zhang J; Zhao X
    Cancer Invest; 2021 Sep; 39(8):675-684. PubMed ID: 34241563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment.
    Kumar MS; Yadav TT; Khair RR; Peters GJ; Yergeri MC
    Curr Pharm Des; 2019; 25(31):3323-3338. PubMed ID: 31475891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
    Li Y; Zhou X; Liu J; Yuan X; He Q
    Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of artemisinin-type drugs for the treatment of acute leukemia.
    Lu X; Efferth T
    Semin Cancer Biol; 2021 Jan; 68():291-312. PubMed ID: 32485311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin and its derivatives: a promising cancer therapy.
    Kiani BH; Kayani WK; Khayam AU; Dilshad E; Ismail H; Mirza B
    Mol Biol Rep; 2020 Aug; 47(8):6321-6336. PubMed ID: 32710388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-derived hybrids and their anticancer activity.
    Gao F; Sun Z; Kong F; Xiao J
    Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
    Li Z; Li Q; Wu J; Wang M; Yu J
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27739410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.
    Morrissey C; Gallis B; Solazzi JW; Kim BJ; Gulati R; Vakar-Lopez F; Goodlett DR; Vessella RL; Sasaki T
    Anticancer Drugs; 2010 Apr; 21(4):423-32. PubMed ID: 20130467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.
    Deng XR; Liu ZX; Liu F; Pan L; Yu HP; Jiang JP; Zhang JJ; Liu L; Yu J
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):862-865. PubMed ID: 24337849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers.
    Zhang S; Yi C; Li WW; Luo Y; Wu YZ; Ling HB
    Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200086. PubMed ID: 35484335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.
    Wong YK; Xu C; Kalesh KA; He Y; Lin Q; Wong WSF; Shen HM; Wang J
    Med Res Rev; 2017 Nov; 37(6):1492-1517. PubMed ID: 28643446
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ishola AA; Adewole KE
    Curr Drug Discov Technol; 2020; 17(5):725-734. PubMed ID: 31284865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
    Kumari K; Keshari S; Sengupta D; Sabat SC; Mishra SK
    BMC Cancer; 2017 Dec; 17(1):858. PubMed ID: 29246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy.
    Zhu S; Yu Q; Huo C; Li Y; He L; Ran B; Chen J; Li Y; Liu W
    Curr Med Chem; 2021; 28(2):329-345. PubMed ID: 31965935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
    Zhang B
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900240. PubMed ID: 31797422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.
    Chen GQ; Benthani FA; Wu J; Liang D; Bian ZX; Jiang X
    Cell Death Differ; 2020 Jan; 27(1):242-254. PubMed ID: 31114026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.